We report a de novo SMARCA2 missense mutation discovered on exome sequencing in a patient with myoclonic astatic epilepsy, leading to reassessment and identification of Nicolaides–Baraitser syndrome. The gene discussed is SMARCA2; the disease is epilepsy with myoclonic atonic seizures.